196 related articles for article (PubMed ID: 26762648)
21. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).
Silverman LB; Stevenson KE; O'Brien JE; Asselin BL; Barr RD; Clavell L; Cole PD; Kelly KM; Laverdiere C; Michon B; Schorin MA; Schwartz CL; O'Holleran EW; Neuberg DS; Cohen HJ; Sallan SE
Leukemia; 2010 Feb; 24(2):320-34. PubMed ID: 20016537
[TBL] [Abstract][Full Text] [Related]
22. Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats.
Thompson KL; Rosenzweig BA; Zhang J; Knapton AD; Honchel R; Lipshultz SE; Retief J; Sistare FD; Herman EH
Cancer Chemother Pharmacol; 2010 Jul; 66(2):303-14. PubMed ID: 19915844
[TBL] [Abstract][Full Text] [Related]
23. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
24. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
de Baat EC; Mulder RL; Armenian S; Feijen EA; Grotenhuis H; Hudson MM; Mavinkurve-Groothuis AM; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014638. PubMed ID: 36162822
[TBL] [Abstract][Full Text] [Related]
25. Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia.
Goldberg JM; Scully RE; Sallan SE; Lipshultz SE
J Pediatr Hematol Oncol; 2012 Jul; 34(5):395-7. PubMed ID: 22584777
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial D-loop polymorphisms and mitochondrial DNA content in childhood acute lymphoblastic leukemia.
Kwok CS; Quah TC; Ariffin H; Tay SK; Yeoh AE
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e239-44. PubMed ID: 21646920
[TBL] [Abstract][Full Text] [Related]
27. Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder.
Lindqvist D; Wolkowitz OM; Picard M; Ohlsson L; Bersani FS; Fernström J; Westrin Å; Hough CM; Lin J; Reus VI; Epel ES; Mellon SH
Neuropsychopharmacology; 2018 Jun; 43(7):1557-1564. PubMed ID: 29453441
[TBL] [Abstract][Full Text] [Related]
28. Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
McComsey GA; Kang M; Ross AC; Lebrecht D; Livingston E; Melvin A; Hitti J; Cohn SE; Walker UA;
HIV Clin Trials; 2008; 9(2):126-36. PubMed ID: 18474497
[TBL] [Abstract][Full Text] [Related]
29. Dexrazoxane for preventing anthracycline cardiotoxicity in children with solid tumors.
Choi HS; Park ES; Kang HJ; Shin HY; Noh CI; Yun YS; Ahn HS; Choi JY
J Korean Med Sci; 2010 Sep; 25(9):1336-42. PubMed ID: 20808678
[TBL] [Abstract][Full Text] [Related]
30. Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival.
Tahover E; Segal A; Isacson R; Rosengarten O; Grenader T; Gips M; Cherny N; Heching NI; Mesika L; Catane R; Gabizon A
Anticancer Drugs; 2017 Aug; 28(7):787-794. PubMed ID: 28562379
[TBL] [Abstract][Full Text] [Related]
31. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.
Lipshultz SE; Lipsitz SR; Mone SM; Goorin AM; Sallan SE; Sanders SP; Orav EJ; Gelber RD; Colan SD
N Engl J Med; 1995 Jun; 332(26):1738-43. PubMed ID: 7760889
[TBL] [Abstract][Full Text] [Related]
32. Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes.
Lipshultz SE; Miller TL; Lipsitz SR; Neuberg DS; Dahlberg SE; Colan SD; Silverman LB; Henkel JM; Franco VI; Cushman LL; Asselin BL; Clavell LA; Athale U; Michon B; Laverdière C; Schorin MA; Larsen E; Usmani N; Sallan SE;
Pediatrics; 2012 Dec; 130(6):1003-11. PubMed ID: 23166343
[TBL] [Abstract][Full Text] [Related]
33. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
34. Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.
Lipshultz SE; Lipsitz SR; Kutok JL; Miller TL; Colan SD; Neuberg DS; Stevenson KE; Fleming MD; Sallan SE; Franco VI; Henkel JM; Asselin BL; Athale UH; Clavell LA; Michon B; Laverdiere C; Larsen E; Kelly KM; Silverman LB
Cancer; 2013 Oct; 119(19):3555-62. PubMed ID: 23861158
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
Limat S; Daguindau E; Cahn JY; Nerich V; Brion A; Perrin S; Woronoff-Lemsi MC; Deconinck E
J Clin Pharm Ther; 2014 Apr; 39(2):168-74. PubMed ID: 24384030
[TBL] [Abstract][Full Text] [Related]
36. Elevated mitochondrial DNA copy numbers in pediatric acute lymphoblastic leukemia: A potential biomarker for predicting inferior survival.
Jain A; Bakhshi S; Thakkar H; Gerards M; Singh A
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29134740
[TBL] [Abstract][Full Text] [Related]
37. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol].
de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M
Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
[TBL] [Abstract][Full Text] [Related]
39. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
Seymour L; Bramwell V; Moran LA
Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
[TBL] [Abstract][Full Text] [Related]
40. Physical Activity in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: A Cross-sectional Cohort Study.
Nayiager T; Barr RD; Anderson L; Cranston A; Hay J
J Pediatr Hematol Oncol; 2017 Jan; 39(1):15-19. PubMed ID: 27571119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
